Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

146.01 -0.15 (-0.10%)
Streaming Delayed Price Updated: 1:06 PM EDT, Jul 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Johnson & Johnson

< Previous 1 2
...
24 25 26 27 28 29 30 31 32
...
99 100 Next >
The 3 Most Undervalued Dow Stocks to Buy in September 2023
These undervalued Dow stocks have multiple, strong and positive catalysts and are poised to deliver strong returns for investors. 
Via InvestorPlace
Topics Stocks
Exposures US Equities
Lawsuit Against Dummy Pills For Allergy, Cold: Johnson & Johnson And Procter & Gamble Face Allegations
In a recent lawsuit, Johnson & Johnson (NYSE: JNJ) and Procter & Gamble Co (NYSE: PG) are facing allegations of misleading consumers regarding decongestant cold medicines conta 
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
3 Blue-Chip Stocks to Watch in the ‘Green Zone’
Now may be the time to take a look at these three blue-chips, as each one is currently in the "Green Zone stocks" category. 
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Johnson & Johnson Marks New Era as Global Healthcare Company With Updated Visual Identity
From Johnson & Johnson
Via Business Wire
Better Buy: J&J vs. Kenvue
You can count on both of these companies for passive income, too. 
Via The Motley Fool
Johnson & Johnson Unusual Options Activity
Via Benzinga
3 Warren Buffett Stocks That Are Near Their 52-Week Lows
Should you consider loading up on these stocks? 
Via The Motley Fool
Buy the Dip: 3 Healthcare Stocks to Snag Now for Supercharged Gains
Unearth the three best healthcare stocks to buy that are poised for long-term growth ahead for savvy investors. 
Via InvestorPlace
Here's My Top Growth Stock to Buy in 2023
The growth train is leaving the station and you don't want to miss it. Find out why this stock remains a strong buy even after doubling in 2023. 
Via The Motley Fool
NY Consulting Firm Predicts Psychedelic Drugs Market Will Generate Over $12B In Next 12 Years
NY-based strategic consulting firm Research Nester launched global market research for psychedelic substances with projections until 2035. 
Via Benzinga
FDA Panel Says Popular OTC Cold, Allergy Medicine Might Be Useless - Stocks To Watch
According to FDA panel experts who reviewed the latest research on the long-questioned phenylephrine, a drug ingredient used in several leading decongestants used by millions of Americans looking for... 
Via Benzinga
Exposures Product Safety
Could This Issue Sink Johnson & Johnson's Stock Price?
Don't be too quick to press the sell button. 
Via The Motley Fool
Analyst Ratings for Johnson & Johnson
Via Benzinga
AstraZeneca's Tagrisso-Chemo Combo Data In Lung Cancer Sets High Bar For Johnson & Johnson's Cancer Drug: Analyst
On Sunday night, AstraZeneca Plc (NASDAQ: AZN) presented the Phase 3 FLAURA2 results evaluating Tagrisso plus chemotherapy versus Tagrisso monotherapy as first-line treatment for patients  
Via Benzinga
AI Integration In Biotech & Pharma: Companies Positioned To Benefit
The convergence of artificial intelligence (AI) with the biotech and pharmaceutical sectors is ushering in a new era of innovation. AI is catalyzing transformations from drug discovery to patient care.... 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Another Arthritis Blockbuster Drug Faces Generic Competition: Novartis' Sandoz Inks Pact With Samsung Bioepis
Sandoz, a generic and biosimilar medicines unit of Novartis AG (NYSE: NVS), has  
Via Benzinga
3 Bulletproof Stocks to Buy Before the Next Recession Strikes
With these three bulletproof stocks, investors seek refuge in stable and growth-oriented stocks as the specter of economic downturns looms. 
Via InvestorPlace
Topics Economy
Exposures Economy
Warren Buffett's Highest-Yielding Stock Isn't Citigroup at 5%. He's Netting Almost 57% Annually From Another Top Holding.
Relative to Berkshire's cost basis in the company, this longtime Buffett holding is generating more than 11 times the nominal yield of Citigroup. 
Via The Motley Fool
The 7 Best Warren Buffett Stocks to Buy Now: September 2023
With investors not sure of their next move, trying your luck with the best Warren Buffett stocks could be a confidence booster. 
Via InvestorPlace
New to Investing? Here's How You Can Get Started With $500.
You don't have to invest a lot to start building a winning portfolio. 
Via The Motley Fool
3 No-Brainer Dividend Stocks to Buy No Matter What the Market Is Doing
You'll want to hold on to these players for the long term. 
Via The Motley Fool
The 5 Best Healthcare Stocks to Buy Now: September 2023
Unearth the best healthcare stocks offering attractive entry points and opportunities for significant returns. Start investing today! 
Via InvestorPlace
September Rally? 3 Healthcare Stocks to Buy Before Liftoff.
The anticipated volume of future healthcare spending makes this a time to look at healthcare stocks to buy for the long term. 
Via InvestorPlace
Dividend Growth Rates and How to Calculate Them
Via MarketBeat
7 Best Blue Chip Stocks to Buy Now
Blue-chip stocks are the stocks of well-known, high-quality industry leaders. Learn more about our top picks for the best blue chip stocks to buy now. 
Via MarketBeat
Global Dry Eye Syndrome Treatment Market Expected to Reach $11.26 Billion By 2030
EQNX::TICKER_START (NASDAQ:OKYO),(NYSE:ALC),(NYSE:BLCO),(NYSE:JNJ),(OTCQX:RHHBY) EQNX::TICKER_END 
Via FinancialNewsMedia
Exposures COVID-19
3 Shaky Stocks to Sell in September Before It’s Too Late
Here's a list of stocks to sell that can put your portfolio at potential risk of losses due to legal exposure or poor performance. 
Via InvestorPlace
The 7 Best Dow Stocks to Buy Now: September 2023
These are the best Dow stocks to buy because they offer long-term growth, a margin of safety and reliability in an otherwise volatile market. 
Via InvestorPlace
Topics Stocks
Exposures US Equities
3 Stocks Awaiting Winter Winds of Opportunity
The change in seasons favors specific stocks like JNJ, GOOS, and MTN, which exhibit growth patterns tied to seasonal changes. 
Via MarketBeat
< Previous 1 2
...
24 25 26 27 28 29 30 31 32
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.